Trump administration ends Medicare drug subsidy program, potentially raising costs

Millions of Medicare beneficiaries, particularly seniors on fixed incomes, may face increased out-of-pocket medication expenses.

In a move that touches the daily lives of millions of older Americans, the Trump administration has chosen to end a Medicare drug subsidy program that long served as a financial buffer between seniors and the full cost of their prescriptions. The decision reflects a deliberate shift in how the federal government weighs its role in pharmaceutical support — a recalibration with consequences that will be felt not in policy documents, but at pharmacy counters across the country. For those living on fixed incomes and managing chronic illness, the question of who bears the cost of staying well is no

Trump administration ends Medicare drug subsidy program, potentially raising costs

Cobertura Relacionada

Recibe The Register en tu bandeja